ArticleWorld journal of oncology2025
Clinical Utility of Targeted Next-Generation Sequencing for Determining Human Epidermal Growth Factor Receptor 2 Status and Optimizing Targeted Therapy in Breast Cancer.
Yoshimi Hara et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.